Skip to main content
. 2016 Apr 20;7(22):33035–33045. doi: 10.18632/oncotarget.8847

Figure 1. Serum PD-L1 levels in healthy controls and ENKTCL patients both pre- and posttreatment.

Figure 1

A. Serum PD-L1 protein levels in 20 healthy subjects and the 97 ENKTCL patients at diagnosis. Serum PD-L1 levels were higher in ENKTCL patients than in healthy volunteers (P<0.001). B. Serum PD-L1 protein levels measured at diagnosis and 1 month after the completion of treatment in the 76 patients with complete remission. Pretreatment serum sPD-L1 levels were higher than post-treatment levels in these patients (P<0.001).